Extensive research has demonstrated that APP/PS1 transgenic mice exhibit robust amyloid plaque pathology akin to that observed in AD and develop age-related memory deficits (Trinchese et al., 2004). This evidence concerns the gene PSEN1 and Alzheimer disease.